Classification of germline variants identified in cancer predisposition genetic testing – consensus of the CZECANCA consortium
Klinicka onkologie · 2023
DOI: 10.48095/ccko2023431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinicka onkologie, 2023. Verfasst von M Janatová und 13 weiteren Autor:innen. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Neoplastic Syndromes, Hereditary.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Zitieren
APA
Janatová, M., Chvojka, Š., Macháčková, E., Soukupová, J., Zemánková, P., Nehasil, P., Zavoral, T., Hrušková, L., Janíková, K. M. K., Lhota, F., Tavandzis, S., Kleiblová, P., Kleibl, Z., & Konzorcium, C. (2023). Classification of germline variants identified in cancer predisposition genetic testing – consensus of the CZECANCA consortium. Klinicka onkologie. https://doi.org/10.48095/ccko2023431
Vancouver
Janatová M, Chvojka Š, Macháčková E, Soukupová J, Zemánková P, Nehasil P, et al. Classification of germline variants identified in cancer predisposition genetic testing – consensus of the CZECANCA consortium. Klinicka onkologie. 2023. doi:10.48095/ccko2023431
BibTeX
@article{Janatov2023,
author = {Janatová, M and Chvojka, Š and Macháčková, E and Soukupová, J and Zemánková, P and Nehasil, P and Zavoral, T and Hrušková, L and Janíková, K M Kozáková and Lhota, F and Tavandzis, S and Kleiblová, P and Kleibl, Z and Konzorcium, Czecanca},
title = {Classification of germline variants identified in cancer predisposition genetic testing – consensus of the CZECANCA consortium},
journal = {Klinicka onkologie},
year = {2023},
doi = {10.48095/ccko2023431}
}
EUVIMED